APA (7th ed.) Citation

Che YQ, Zhang Y, Wang D, Liu HY, Shen D, & Luo Y. (2019). Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab. Dove Medical Press.

Chicago Style (17th ed.) Citation

Che YQ, Zhang Y, Wang D, Liu HY, Shen D, and Luo Y. Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 Positive Metastatic Breast Cancer Treated With Trastuzumab. Dove Medical Press, 2019.

MLA (9th ed.) Citation

Che YQ, et al. Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 Positive Metastatic Breast Cancer Treated With Trastuzumab. Dove Medical Press, 2019.